Abstract-Intermolecular interactions between members of both similar and divergent G protein-coupled receptor subfamilies have been shown in various experimental systems. Here, we demonstrate heterodimerization of predominant ␤-adrenergic receptor (␤AR) subtypes expressed in the heart, ␤ 1 AR, and ␤ 2 AR, and its physiological relevance. In intact adult-mouse cardiac myocytes lacking native ␤ 1 AR and ␤ 2 AR, coexpression of both ␤AR subtypes led to receptor heterodimerization, as evidenced by their coimmunoprecipitation, colocalization at optical resolution, and markedly increased binding affinity for subtype-selective ligands. As a result, the dose-response curve of myocyte contraction to ␤AR agonist stimulation with isoproterenol (ISO) was shifted leftward by Ϸ1.5 orders of magnitude, and the response of cellular cAMP formation to ISO was enhanced concomitantly, indicating that intermolecular interactions of ␤AR subtypes resulted in sensitization of these receptors in response to agonist stimulation. In contrast, the presence of ␤ 1 AR greatly suppressed ligand-independent spontaneous activity of coexisting ␤ 2 ARs. Thus, heterodimerization of ␤ 1 AR and ␤ 2 AR in intact cardiac myocytes creates a novel population of ␤ARs with distinct functional and pharmacological properties, resulting in enhanced signaling efficiency in response to agonist stimulation while silencing ligandindependent receptor activation, thereby optimizing ␤-adrenergic modulation of cardiac contractility. 
G protein-coupled receptors (GPCRs) represent the largest family of transmembrane molecules involved in cell signal transduction. GPCRs have traditionally been thought to function as monomers, but increasing evidence suggests that GPCRs may exist as both homodimers or heterodimers. [1] [2] [3] [4] [5] [6] [7] The idea that GPCRs might undergo dimerization was first proposed in 1982. 8 The physical interaction of GPCRs within or among different families leads to a multitude of changes in ligand binding and signaling properties of these receptors. 1-7,9 -11 However, a close inspection of previous studies reveals that most have been conducted in naive cell lines or in vitro experimental settings. An important question is, however, whether GPCR dimerization occurs in a physiological context such as the intact cardiomyocyte and, if so, whether this has physiological or pathophysiological relevance.
As prototypical members of the GPCR superfamily, ␤-adrenergic receptors (␤AR) consist of 3 pharmacologically and genetically distinct subtypes, ␤ 1 AR, ␤ 2 AR, and ␤ 3 AR, which are often coexpressed in many types of cells and tissues. In cardiomyocytes, mainly ␤ 1 AR and ␤ 2 AR subtypes are coexpressed and fulfill distinct functional roles via activation of subtype-specific signaling pathways. 12 Our previous studies have shown that heterodimerization between ␤ 1 AR and ␤ 2 AR subtypes inhibits ␤ 2 AR internalization and its ability to activate ERK1/2 MAPK signaling in HEK293 cells. 11 The present study is aimed to characterize potential heterodimerization of these ␤AR subtypes in the heart and its impacts on the functional and signaling properties of these receptors. To create "pure" ␤ 1 AR, ␤ 2 AR, or ␤ 1 ␤ 2 coexistent systems with a matched total receptor density, we expressed either the mouse ␤ 1 AR or ␤ 2 AR, or both subtypes in cardiomyocytes from the adult ␤ 1 AR and ␤ 2 AR double knockout (␤ 1 ␤ 2 AR DKO) mice, 13 in conjunction with adenoviral gene transfer techniques. 14 Our results indicate that ␤ 1 AR and ␤ 2 AR are able to form heterodimers in intact cardiomyocytes, and that the heterodimeric receptors exhibit altered ligand binding profiles, enhanced signaling efficiency in regulating myocyte cAMP production and contractility, and suppressed ␤ 2 AR spontaneous activity in the absence of agonist stimulation. Thus, we conclude that ␤ 1 AR and ␤ 2 AR heterodimerization is required for optimal ␤-adrenergic regulation of cardiac contractility.
Materials and Methods

Cardiac Myocyte Adenoviral Infection and Cell Contraction Measurement
Single cardiomyocytes were isolated from the hearts of Ϸ2-to 3-month-old male ␤ 1 ␤ 2 AR DKO or ␤ 1 AR KO or wild-type (WT) mice with an enzymatic technique, then cultured and infected with adenoviral vectors for 24 hours, as described previously. 14 Cultured cells were then perfused with a HEPES-buffered solution (in mmol/L: NaCl 137, KCl 5.4, MgCl 2 1.2, NaH 2 PO 4 1, CaCl 2 1, glucose 20, and HEPES 20, pH 7.4), and electrically stimulated at 0.5 Hz at 23°C. Cell contraction was measured by the percent shortening of cell length in response to electrical stimulation. 15 
cAMP Measurement
Intracellular cAMP levels were assayed by radioimmunoassay, as previously described. 16 Briefly, cultured mouse cardiomyocytes were incubated with isoproterenol (ISO) for 10 minutes, and cellular cAMP formation was determined using a radioimmunoassay kit from Amersham with a duplicate in each experiment.
Radioligand-Binding Assay
As described previously, 16 binding assays were performed on 25 g of membrane proteins using saturating amounts of the ␤AR specific ligand [ 
Immunocytochemical Staining and Confocal Imaging
Immunocytochemical staining and confocal imaging were performed in ␤ 1 ␤ 2 AR DKO cells infected by either adv-␤ 1 AR tagged with hemagglutinin (HA), or adv-␤ 2 AR, or a combination of both, at multiplicity of infection (moi) 100 for 24 hours, as described previously. 16 Horse anti-mouse IgG secondary antibodies and goat anti-rabbit IgG secondary antibodies were used for ␤ 1 AR and ␤ 2 AR staining, respectively. Immunofluorescence was then detected by a confocal microscope (LSM-510, Zeiss) with an optical section thickness of 1.0 m.
Coimmunoprecipitation and Western Blotting
Myocytes expressing HA-tagged ␤ 1 AR, Flag-tagged ␤ 2 AR, or both receptors were lysed in RIPA buffer (in mmol/L: 50 Tris pH 7.4, 150 NaCl, 20 ␤-glycerophosphate, 20 NaF, 0.2 Na 3 VO 4 , 5 EDTA, 5 EGTA, 10 benzamidine, 0.5 PMSF, 1 PMSF, 25 g/mL leupeptin, 1% Triton X-100, and 0.5% sodium deoxycholate) for 30 minutes at 4°C. For immunoprecipitation, 100 to 200 g of protein was incubated with 1 to 2 g of anti-Flag (1:100) or anti-HA (1:100) overnight at 4°C to pull-down Flag-tagged ␤ 2 AR or HA-tagged ␤ 1 AR, respectively. Immunocomplexes were isolated by incubation with 10% vol/vol protein G-Sepharose for 2 to 3 hours. The immunoprecipitate was then treated with 100 mmol/L DTT in the sample buffer and subjected to SDS/PAGE and Western blotting to detect the presence of ␤ 1 AR or ␤ 2 AR with the anti-HA monoclonal antibody or the anti-Flag antibody, respectively. In addition, we have quantified the relative percentage of heterodimer of ␤ 1 /␤ 2 AR (pulldown with anti-HA antibody or anti-Flag antibody, normalized by anti-body pull-down efficiency) compared with the total ␤ 1 /␤ 2 AR pool (cell lysate). 
Materials
Statistical Analysis
Data were expressed as meanϮSE. Statistical comparisons used 1-way ANOVA followed by the Bonferroni procedure for multiplegroup comparisons. A PϽ0.05 was considered statistically significant.
Results
Colocalization of ␤AR Subtypes in Cardiomyocytes
To investigate possible intermolecular interactions between ␤ 1 AR and ␤ 2 AR subtypes, we expressed either or both ␤AR subtypes in cultured ventricular myocytes from ␤ 1 ␤ 2 AR DKO mice using adenovirus-mediated gene transfer at moi of 100. After 24 hours infection, the densities of ␤ 1 AR and ␤ 2 AR were comparable to that of cells expressing both ␤AR subtypes (Table 1) . Using confocal immunocytochemical imaging, we visualized that the specific immunofluorescence of ␤ 1 AR or ␤ 2 AR was largely concentrated on cell surface membranes, including transverse tubules, with enriched staining of the perinuclear area ( Figure 1A ). An overlay of the images of HA-␤ 1 AR and ␤ 2 AR revealed an excellent pixelto-pixel correlation (r 2 ϭ0.78, Figure 1B ), an indication of colocalization of ␤ 1 AR and ␤ 2 AR at optical resolution.
Coimmunoprecipitaiton of ␤ 1 AR and ␤ 2 AR
To directly demonstrate physical association of ␤AR subtypes, we expressed HA-tagged ␤ 1 AR or Flag-tagged ␤ 2 AR or both in the null background of DKO myocytes and then performed immunoprecipitation and Western blot assays. Total cellular proteins containing either or both ␤AR subtypes were first immunoprecipitated with a rabbit polyclonal anti-Flag antibody. The pull-down of Flag-tagged ␤ 2 AR in the immunoprecipitate was confirmed by Western blot using the anti-Flag antibody ( Figure 1C, top) . Notably, the presence of ␤ 1 AR in the immunoprecipitate was detected by Western blot using a mouse monoclonal anti-HA antibody ( Figure 1C , Note: ventricular myocytes from WT or ␤ 1 AR KO mice or those from DKO mice infected by Adv-␤ 1 AR (moi of 100) or Adv-␤ 2 AR (moi of 100) or both (moi of 50 for each), (nϭ3 to 4 independent experiments each performed in duplicate). bottom). Three major species (Mr: Ϸ52 kDa, Ϸ70 kDa, and 150 kDa) were visualized with the Western blot. Three similar immunoreactive species (Mr: 50, 70, 150 kDa) were illustrated by Western blot using anti-HA in the total extracts from cells expressing HA-␤ 1 AR ( Figure 1D ). The Ϸ50 kDa species likely represents the monomeric form of HA-␤ 1 AR, and the 150 kDa form likely represents SDS-resistant homodimeric receptors (or oligomers). The Ϸ70-kDa species might represent the monomeric core glycosylated form of HA-␤ 1 -AR. As a negative control, there was no detectable HA-immunoreactivity in myocytes expressing either ␤ 2 AR alone or ␤-gal ( Figure 1D ). Conversely, we performed the coimmunoprecipitation experiments with the anti-HA antibody to pull-down ␤ 1 ARs and detected coimmunoprecipitated Flag-tagged ␤ 2 ARs by Western blot using rabbit polyclonal anti-Flag ( Figure 1E ). The specificity of anti-Flag was confirmed by the immunoreactive signals in the total extracts from cells expressing Flag-␤ 2 AR but not in those expressing HA-␤ 1 AR alone or ␤-gal ( Figure 1F ). In an attempt to quantify the relative proportions of receptor heterodimers, we determined the pull-down efficiency of each antibody (by comparing pull-down with whole cell lysate) and measured the relative amount of the other tagged receptor coimmunoprecipitated. Heterodimers represented 18.9Ϯ4.6% (nϭ3) and 21.0Ϯ5.6% (nϭ3) of the total ␤ 1 ARs and ␤ 2 AR populations, as indexed by their coimmunoprecipitation. These B, Pixel-to-pixel correlation of ␤ 1 AR and ␤ 2 AR immunofluorescence. Color encodes the number of pixels corresponding to each data point. The line refers to a linear regression of the data (r 2 ϭ0.78). Negative controls (in the absence of primary antibody) showed negligible immunofluorescence (not shown). C, Coimmunoprecipitation of coexpressed ␤AR subtypes. Myocytes were infected with adenoviruses encoding HA-␤ 1 AR or Flag-␤ 2 AR individually or in combination for 24 hours. ␤ 2 ARs were immunoprecipitated using a rabbit polyclonal anti-Flag antibody and Western blots were performed to confirm pull-down of Flag-tagged ␤ 2 AR in the inmmunoprecipitates. The presence of HA-␤ 1 AR in the immunoprecipitate was detected by Western blot using a mouse monoclonal anti-HA antibody. D, Typical Western blot of total cellular extracts using the anti-HA antibody. E, Reverse coimmunoprecipitation of coexpressed ␤AR subtypes. The experimental protocols were similar to that used in panel C. ␤ 1 AR was immunoprecipitated using the anti-HA antibody, and Western blots were performed to confirm pull-down of HA-tagged ␤ 1 AR in the inmmunoprecipitates. The presence of Flag-␤ 2 AR in the immunoprecipitate was assayed by Western blot with the anti-Flag antibody. F, Typical Western blot of total cellular extracts using the antiFlag antibody. Throughout all of the experiments, immunocomplexes were analyzed by SDS-PAGE (4% to 20% gradient gels). C through F, the Western blots are representative of at least 3 experiments with each on cells from 3Ϸ4 mouse hearts.
results indicate that intermolecular interactions occur between ␤ 1 AR and ␤ 2 AR in adult-mouse cardiomyocytes.
Suppression of Spontaneous ␤ 2 AR Activation by ␤ 1 AR Coexpression
To determine the functional consequences of ␤ 1 AR-␤ 2 AR heterodimerization in adult-mouse ventricular myocytes, we first examined constitutive ␤AR activity in the absence of agonist stimulation. The baseline contractility of cells expressing ␤ 2 AR was enhanced by 1.6-fold relative to myocytes expressing ␤ 1 AR or those uninfected cells from WT or DKO mice (Figure 2A ). In contrast, expression of ␤ 1 AR at a receptor density that matched the ␤ 2 AR density did not alter basal ligand-independent myocyte contraction amplitude (Figure 2A ). ICI 118 551 (ICI, 5ϫ10
Ϫ7 mol/L), a ␤ 2 AR inverse agonist, completely reversed the enhanced basal contraction ( Figure 2B ), without altering the baseline contraction in cells expressing ␤ 1 AR (data not shown). These results are consistent with the previous notion that ␤ 2 AR, 16 -20 but not ␤ 1 AR, 16, 21 exhibits spontaneous activity. Surprisingly, the Adv-␤ 2 AR infection-induced augmentation in the baseline contractility was fully prevented when cells were coinfected with Adv-␤ 1 AR (50 moi for each) (Figure 2A ). This was not caused by a reduction in ␤ 2 AR subtype density, because Adv-␤ 2 AR alone (50 moi) significantly elevated, in an ICI-sensitive manner, the baseline contractility relative to that of uninfected WT or DKO cells or Adv-␤ 1 AR infected myocytes (Figure 2A ). It is noteworthy that there was no significant difference in the baseline contraction amplitude between WT and ␤ 1 AR KO groups (3.6Ϯ0.7 and 3.7Ϯ0.5% of resting cell length, nϭ35 and 38 cells, respectively) ( Figure 2A ). This might be explained by the relatively modest density of the native ␤ 2 ARs in the ␤ 1 AR KO cells, because the spontaneous activity of the ␤ 2 AR is receptor density-dependent. 16 -20 Figure 2B
shows representative examples of the inhibitory effect of ICI in a cell expressing either ␤ 2 AR or both ␤AR subtypes (top and bottom, respectively). Clearly, coexpression of ␤ 1 AR virtually abolished spontaneous ␤ 2 AR activity, as manifested by the inability of the ␤ 2 AR inverse agonist to reduce basal myocyte contraction (Figure 2A and 2B) .
Heterodimerization of ␤AR Subtypes Enhances Cardiomyocyte Contractile Response to ␤AR Agonist Stimulation
Next, we determined the potential impact of coexpression of these receptors on the myocyte contractile response to agonistinduced ␤AR stimulation. In cells expressing either ␤ 1 AR or ␤ 2 AR, stimulation of these ␤AR subtypes with the same agonist, isoproterenol (ISO), produced comparable maximal contractile responses despite their distinct basal contraction amplitudes ( Figure 3A) . When the concentration-response curves were normalized by their corresponding basal level or maximal response ( Figure 3B and Figure 3C , respectively), it is clear that the concentration-response curves of ␤ 1 AR-and ␤ 2 AR-mediated increases in myocyte contractility virtually overlapped with each other with pD2 (-log EC 50 ) of 9.02Ϯ0.03 and 8.23Ϯ0.29 (nϭ6 to 8 for both groups), respectively ( Figure 3B and 3C) . However, in myocytes coexpressing ␤ 1 AR and ␤ 2 AR at a similar total receptor density, the concentration-response curve of ISO- induced relative increase in myocyte contractility was shifted leftward by 1.5 orders of magnitude (pD2 10.41Ϯ0.49; PϽ0.01 versus the ␤ 1 AR or the ␤ 2 AR group). Thus, ␤AR subtype heterodimerization sensitizes the contractile response to ligandinduced receptor stimulation in cardiac myocytes.
Cellular cAMP Responses in ␤ 1 AR-or ␤ 2 AR-or Mixed ␤ 1 ␤ 2 AR-Expressing Cardiomyocytes
Because both ␤ 1 AR-and ␤ 2 AR-induced positive inotropic effects are mediated by a cAMP-dependent mechanism, [21] [22] [23] we next investigated the cAMP response to ␤AR stimulation in DKO cardiomyocytes expressing either or both ␤AR subtypes. Compared with that of uninfected WT or DKO cells, the baseline cAMP level was unchanged in myocytes expressing ␤ 1 AR, but augmented by 2.1-fold in cells infected with Adv-␤ 2 AR (100 moi) ( Figure 4A ), caused by spontaneous ␤ 2 AR activity. 16 -20 Coexpression of the ␤ 1 AR with ␤ 2 AR fully suppressed the ␤ 2 AR-induced increase in basal cAMP production ( Figure 4A) , as was the case for the baseline contractility ( Figure 2 ). The absolute increase in cAMP formation in response to ISO in cells expressing ␤ 2 AR was increased versus that in cells expressing ␤ 1 AR ( Figure 4B) . However, the relative response of cAMP formation (% of basal level) to ISO was greater in ␤ 1 AR-expressing cells compared with that in those expressing ␤ 2 AR ( Figure 4C ). Remarkably, when these ␤AR subtypes were coexpressed in ␤ 1 ␤ 2 AR DKO cardiomyocytes at matched levels of total receptor expression, the ISO-induced absolute or relative increase in cAMP formation was almost 2-fold greater than that in cells expressing either ␤ 1 AR or ␤ 2 AR alone ( Figure 4B and 4C), consistent with the profile of myocyte contractile response to either spontaneous or ligand-induced ␤AR subtype activation.
Ligand Binding Profiles of ␤ 1 AR, ␤ 2 AR, and Coexpressed ␤AR Subtypes
In addition to the aforementioned immunocytochemical, physiological, and biochemical data, differences in ligandreceptor interactions would provide strong pharmacological evidence for receptor dimerization. In this regard, we examined ligand-binding profiles in WT or in DKO mouse cardiomyocytes when ␤AR subtypes were individually expressed or coexpressed. There were 2 ␤AR subpopulations in WT mouse heart with 73.6Ϯ2.7% and 26.4Ϯ2.9% for ␤ 1 AR for ␤ 2 AR, respectively. Most importantly, radioligand binding assays revealed that the binding affinity of separately expressed ␤ 1 AR or ␤ 2 AR in DKO cells for their selective ligands, CGP 20712A or ICI 118 551, was reduced by Ϸ30-fold and Ϸ10-fold, respectively, compared with that in WT cells or DKO myocytes expressing both ␤AR subtypes ( Table 2 ). The coexpression-induced increase in the binding affinity for subtype-selective ligands was not influenced by the absolute densities or the ratio of these ␤AR subtypes, because it occurred in both WT and coinfected DKO mouse myocytes regardless of their different densities or the ratio of the coexisting ␤AR subtypes (Tables 1 and 2 ). That coexpression enhances the affinity of both ␤ 1 AR and ␤ 2 AR for their selective ligand binding further supports the notion that of these receptors form heterodimers in intact adult-mouse cardiomyocytes. 100) or Adv-␤ 2 AR (moi of 100) or both (moi of 50 for each). *PϽ0.01 vs ␤ 1 AR KO or DKO expressing either ␤ 1 AR or ␤ 2 AR (nϭ3 to 6 independent experiments each with duplicates).
Discussion
␤ 1 AR and ␤ 2 AR Heterodimerization Underlying Altered Signaling Properties of These Receptors
In the present study, using immunocytochemical, biochemical, physiological, and pharmacological approaches, we have provided the first documentation of intermolecular interactions between ␤ 1 AR and ␤ 2 AR in intact adult mouse cardiac myocytes. Heterodimerization of these receptors suppresses constitutive ligand-independent ␤ 2 AR signaling, but facilitates receptor-ligand interactions, thereby increasing the signaling efficiency of both ␤AR subtypes and optimizing ␤AR-mediated modulation of cardiac contractility. This conclusion is based on several independent lines of evidence. First, when coexpressed in adult-mouse cardiac myocytes lacking native ␤ARs, ␤ 1 AR and ␤ 2 AR are physically associated with each other, as manifested by their coimmunoprecipitation and intracellular colocalization at optical resolution. Second, coexpression of ␤ 1 AR and ␤ 2 AR creates a novel population of ␤ARs endowed with increased binding affinity for subtype-specific ligands regardless of the total receptor density or the ratio of these receptor subtypes (Tables 1 and  2) . Perhaps most importantly, the presence of ␤ 1 AR fully quenches the spontaneous activity of coexpressed ␤ 2 ARs, as evidenced by a full reversal of agonist-independent ␤ 2 ARmediated augmentation in basal myocyte cAMP production and contractility. This finding provides compelling evidence for constitutive intermolecular interactions between these ␤AR subtypes, because downstream regulatory events are unlikely to be involved in the absence of agonist stimulation. The enhanced ligand binding might contribute, at least in part, to the sensitization of myocyte contractile and cAMP responses to ␤AR agonist stimulation (Figures 3 and 4) .
Interestingly, there are important differences between the present study in native cardiac myocytes and our previous studies performed in HEK 293 cells. 11, 24, 25 Specifically, high-affinity binding to subtype-selective ligands was reduced, rather than increased, in HEK 293 cells coexpressing both ␤ 1 AR and ␤ 2 AR relative to those expressing a single subtype. 25 Moreover, coexpression of both ␤AR subtypes is not associated with an increased cAMP formation in response to agonist stimulation in HEK 293 cells. 11 These obvious discrepancies between intact cardiomyocytes and naive cells underscore that cell-specific factors certainly influence the properties of receptor signaling, and highlights the importance and necessity to validate these issues in a native cellular context.
Optimizing ␤AR-Mediated Modulation of Cardiac Contractility by Subtype Heterodimerization
Although a large number of other GPCRs have been previously reported to undergo homodimerization or heterodimerization, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] the present study provides the first demonstration that ␤ 1 AR and ␤ 2 AR, prototypical members of the GPCR superfamily, form heterodimers in the physiological context of intact cardiac myocytes. When ␤ 1 AR and ␤ 2 AR are coexpressed, myocyte contractile or cAMP response to ␤AR agonist stimulation is profoundly sensitized compared with the "pure" ␤ 1 AR or ␤ 2 AR system, indicating that ␤ 1 AR and ␤ 2 AR interact in a synergistic fashion. Similar functional synergy between ␤ 1 AR and ␤ 2 AR in regulating cAMP production has been previously reported in cultured rat C6 glioma cells. 26 These present findings might imply that in cardiac myocytes, the native ␤ 1 AR and ␤ 2 AR may require mutual support from each other to maintain optimal sympathetic control over heart rate and myocardial contractile performance, allowing the heart to increase its output several times within seconds in response to a "fight-or-flight" situation. In this regard, previous studies have demonstrated that in mice lacking native ␤ 1 AR, stimulation of the native cardiac ␤ 2 AR with ISO was unable to elicit a positive inotropic effect in vivo. 27 This further supports the perception that ␤ 1 AR and ␤ 2 AR exhibit a synergistic interaction in their modulation of cardiac contractility.
It is noteworthy that heterodimerization of ␤ 1 AR and ␤ 2 AR, although enhancing agonist-induced signaling, silences the spontaneous activation of ␤ 2 AR, suggesting that heterodimerization might mutually stabilize both receptor subtypes in their respective inactive conformations in the absence of agonist. As a result, it might reduce the signaling background, but optimize the responsiveness of dimeric receptors to agonist stimulation, thus further synchronizing the sympathetic control over cardiac performance in response to exercise or stress. The exact mechanism underlying the inhibitory effect of ␤ 1 AR on ␤ 2 AR spontaneous activation awaits future investigation. Altogether, our present and previous studies 11, 24, 25 have demonstrated that intermolecular interactions between ␤ 1 AR and ␤ 2 AR create a new population of receptors in terms of their pharmacology, trafficking, signaling, and functionality.
It has been shown that during the progression to heart failure caused by a variety of etiologies, there is a selective downregulation of ␤ 1 AR with little or no change in ␤ 2 AR density. 28 -30 The heart failure-associated decrease in the ratio of ␤ 1 AR to ␤ 2 AR might alter the heterodimerization of the remaining ␤ARs, thus contributing to the diminution of ␤AR contractile support or an upregulation of anti-apoptotic ␤ 2 AR signaling. [31] [32] [33] These hypotheses merit further investigation.
Heterodimerization Between ␤AR and Members From Other GPCR Families
In addition to the complicated impacts of heterodimerization of the closely related ␤ 1 AR and ␤ 2 AR on their trafficking and signaling properties, recent studies have revealed evidence for heterodimerization of ␤ 2 AR with other members of adrenergic receptor family, including ␤ 3 AR, ␣ 2A AR, and ␣ 1D AR, in HEK 293 cells. 34 -36 Interestingly, whereas either ␤ 2 AR or ␤ 3 AR alone couples to both G s and G i proteins, the ␤ 2 AR-␤ 3 AR heterodimer is unable to activate G i signaling. 34 Equally appealing, the heterodimerization of ␤ 2 AR with either ␣ 2A AR or ␣ 1D AR leads to cross-internalization of the receptors on agonist stimulation of either ␤ 2 AR or the ␣AR subtypes, 35, 36 and enables ␣ 1D AR to regulate intracellular Ca 2ϩ mobilization in response to agonist stimulation. 36 Moreover, oligomerization of opioid peptide receptors with ␤ 2 AR also alters receptor trafficking and signal transduction. [37] [38] [39] Additionally, it has been demonstrated that intermolecular interactions between ␤AR and angiotensin II type 1 receptor (AT1R) occurring in the heart leads to a cross-inhibition of their downstream signaling and trafficking by either type of receptor antagonist. 40 Thus, oligomerization of GPCRs from the same or different families not only increases the complexity of GPCR signaling and their functional diversity, but also raises important therapeutic considerations.
In summary, the present results indicate that the ␤ 1 AR and ␤ 2 AR are able to form heterodimers in adult-mouse cardiomyocytes, and that the heterodimeric receptors exhibit altered pharmacological and signaling properties, resulting in more potent cAMP and contractile responses to agonist stimulation, while silencing ligand-independent spontaneous ␤ 2 AR activity. The heterodimeric ␤ 1 AR-␤ 2 AR may represent a pharmacologically and functionally distinct population of ␤ARs. Thus, many well-established paradigms for ␤AR signaling and function may need to be revisited in the context of the coexistence of multiple receptor subtypes and their homo-or heterodimerization.
